These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The quest for liver fibrosis biomarkers: promises from the enhanced liver fibrosis panel and beyond. Yilmaz Y; Ulukaya E; Dolar E Hepatology; 2009 Mar; 49(3):1056-7. PubMed ID: 19133647 [No Abstract] [Full Text] [Related]
5. The extracellular matrix of the liver. Rojkind M; Ponce-Noyola P Coll Relat Res; 1982 Mar; 2(2):151-75. PubMed ID: 7049553 [No Abstract] [Full Text] [Related]
6. Harmony in liver fibrosis.. Bedossa P J Hepatol; 2010 Mar; 52(3):313-4. PubMed ID: 20133004 [No Abstract] [Full Text] [Related]
7. Quantitative collagen as a golden standard in differential diagnosing of fibrotic changes in liver tissue. Jonsson J; Babic A Stud Health Technol Inform; 1999; 68():749-54. PubMed ID: 10724994 [TBL] [Abstract][Full Text] [Related]
8. [Proteoglycans (their structure, function and role in liver diseases)]. Kovalszky I; Jeney A; Lapis K Orv Hetil; 1993 Sep; 134(37):2019-26. PubMed ID: 8414446 [TBL] [Abstract][Full Text] [Related]
9. [Current status of pathobiochemistry and clinico-chemical laboratory diagnosis of liver fibrosis]. Gressner AM Med Klin (Munich); 1987 Oct; 82(20):700-10. PubMed ID: 3316964 [No Abstract] [Full Text] [Related]
10. Collagen breakdown products as markers of fibrosis and cirrhosis. Niemelä O Alcohol Alcohol Suppl; 1994; 2():345-52. PubMed ID: 8974354 [TBL] [Abstract][Full Text] [Related]
11. Liver fibrosis. Rojkind M; Pérez-Tamayo R Int Rev Connect Tissue Res; 1983; 10():333-93. PubMed ID: 6315623 [No Abstract] [Full Text] [Related]
12. [Fractal analysis of liver fibrosis]. Soda G; Nardoni S; Bosco D; Grizzi F; Dioguardi N; Melis M Pathologica; 2003 Apr; 95(2):98-102. PubMed ID: 12768879 [TBL] [Abstract][Full Text] [Related]
13. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between serum fibrosis markers and fibrosis quantitative analysis of liver tissue]. Gu S; Zhang H; Zhang L Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):199-200. PubMed ID: 10715785 [TBL] [Abstract][Full Text] [Related]
15. Hepatic proteoglycans--a brief survey of their pathobiochemical implications. Gressner AM Hepatogastroenterology; 1983 Dec; 30(6):225-9. PubMed ID: 6373541 [No Abstract] [Full Text] [Related]
16. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Gressner OA; Weiskirchen R; Gressner AM Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697 [TBL] [Abstract][Full Text] [Related]
17. Vitronectin in the cirrhotic liver: an immunomarker of mature fibrosis. Koukoulis GK; Shen J; Virtanen I; Gould VE Hum Pathol; 2001 Dec; 32(12):1356-62. PubMed ID: 11774169 [TBL] [Abstract][Full Text] [Related]
18. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of the fraction composition of collagen in liver tissue]. Proshina LIa; Privalenko MN Vopr Med Khim; 1982; 28(1):115-9. PubMed ID: 7064375 [No Abstract] [Full Text] [Related]
20. The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis. Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Calatroni A Chem Biol Interact; 2004 Jul; 148(3):125-38. PubMed ID: 15276869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]